Covidien Ltd. (NYSE:COV)

CAPS Rating: 5 out of 5

The Company is in the business of developing, manufacturing and distributing medical devices and supplies, diagnostic imaging agents, pharmaceuticals and other healthcare products for use in clinical and home settings.

Recs

0
Player Avatar Superannuation (38.15) Submitted: 12/30/2010 11:52:36 PM : Outperform Start Price: $44.37 COV Score: +14.93

50 crossing 200 strong fundamentals

Featured Broker Partners


Advertisement